CLSPN and familial pancreatic carcinoma: We conclude that Claspin and associated regulatory factors including Mre11 and Chk1 could be therapeutically targeted by E1B19K-deleted oncolytic viruses and/or novel inhibitors to better manage treatment-insensitive pancreatic cancers in particular.